Time since initiation of treatment (mos)
OS
in CRs
P = 0.054
no RT
88%
IF RT
82%
median follow-up 6 years
EORTC H34 Trial 1988-2001
Overall Survival n= 736
Aleman
et al., NEJM
2003; 348:2396-406